Kangfang Biotech (09926) plans to add no more than HK$200 million to purchase shares in the open market

Zhitongcaijing · 1d ago

According to the Zhitong Finance App, Kang Fang Biotech (09926) issued an announcement. On November 17, 2026, the company's board of directors approved an additional amount of no more than HK$200 million to purchase the company's shares on the open market. The proposed share purchase will be executed by the trustee of the Company's 2021 Restricted Share Unit Plan. The Board believes that the current transaction price of the shares does not reflect the intrinsic value and growth potential of the company. The proposed share purchase shows that the board of directors and management are confident in the company's business outlook and prospects. The proposed purchase of shares would be disbursed from the company's existing available cash resources.